Moneta Group Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-100,649
| Closed | -$1.24M | – | 292 |
|
2020
Q2 | $1.24M | Sell |
100,649
-1,578
| -2% | -$19.5K | 0.12% | 103 |
|
2020
Q1 | $918K | Buy |
+102,227
| New | +$918K | 0.1% | 114 |
|
2018
Q2 | – | Sell |
-1,000
| Closed | -$17K | – | 617 |
|
2018
Q1 | $17K | Buy |
+1,000
| New | +$17K | ﹤0.01% | 413 |
|
2017
Q1 | – | Sell |
-6,572
| Closed | -$238K | – | 173 |
|
2016
Q4 | $238K | Buy |
+6,572
| New | +$238K | 0.05% | 147 |
|
2016
Q3 | – | Sell |
-16,835
| Closed | -$846K | – | 157 |
|
2016
Q2 | $846K | Buy |
16,835
+1,721
| +11% | +$86.5K | 0.19% | 76 |
|
2016
Q1 | $809K | Buy |
15,114
+7,089
| +88% | +$379K | 0.18% | 73 |
|
2015
Q4 | $527K | Sell |
8,025
-4,774
| -37% | -$314K | 0.13% | 73 |
|
2015
Q3 | $723K | Sell |
12,799
-231
| -2% | -$13K | 0.2% | 53 |
|
2015
Q2 | $770K | Buy |
13,030
+1,160
| +10% | +$68.6K | 0.24% | 51 |
|
2015
Q1 | $740K | Buy |
11,870
+3,280
| +38% | +$204K | 0.32% | 64 |
|
2014
Q4 | $494K | Buy |
8,590
+2,515
| +41% | +$145K | 0.24% | 76 |
|
2014
Q3 | $327K | Buy |
+6,075
| New | +$327K | 0.17% | 99 |
|